SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Skinvisible Inc (SKVI)

SKVI RSS Feed
Add SKVI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 11/3/2016 6:34:54 PM - Followers: 14 - Board type: Free - Posts Today: 0
 
 
 
 
 
 
 
Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.433.7192
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.
 
 
WHO Official: Swine Flu Epidemic Still In Early Stages

Keiji Fukuda, WHO's Assistant Director-General for Health Security and Environment, said that given the size of the world's population, the new H1N1 virus is likely to spread for some time.
  • WHO earlier estimated that as many as 2 billion people could become infected over the next two years — nearly one-third of the world population.
  • Authorities in Britain say there were over 100,000 infections in England alone last week
  • U.S. health officials estimate the United States has passed the 1 million case mark. Those figures dwarf WHO's tally of 130,000 confirmed cases worldwide since the start of the outbreak last spring.
  • WHO announced that almost 800 people have died from the disease in the past four months. This is more than the H5N1 bird flu strain has killed in six years.
  • The CDC said the number of Americans dying from swine flu over the next two years could range from 90,000 to several hundred thousand.


Swine Flu Virus Prevention:

Skinvisible’s DermSafe chlorhexidine hand sanitizer has been tested against many bacteria and viruses. It has been proven to kill / inactivate a number of influenza A viruses; including a strain of H1N1; the swine flu virus.    Click here to read more...


Skinvisible in the News:

CBS News Station: Watch the television news cast featuring
SKINVISIBLE’S DERMSAFE AND HOW IT PROTECTS AGAINST H1N1
Read the newspaper article featuring
DERMSAFE MADE BY SKINVISIBLE

Note: DermSafe is currently not available for sale in the USA.

Skinvisible Pharmaceuticals, Inc.

Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts and dermatitis along with sunscreens, anti-aging products, alcohol-free hand sanitizing lotions, pre-surgical preparations, and various other medical treatments using its patented technology Invisicare®. Skinvisible's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Click here to see current licensees.

The Technology: Invisicare® offers numerous benefits including binding products to the skin for 4 hours+ and more, while resisting wash-off and rub-off. It also enhances the efficacy of ingredients, reduces irritation and can reduce costs. Skinvisible has developed a portfolio of 25+ skincare products using Invisicare and also works directly with companies to enhance their products, especially ones coming off patent. Learn more at www.invisicare.com .

Intellectual Property: Skinvisible's value lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare. Patent approvals are sought (in the U.S. and internationally) for all products developed. There are 4 patents approved, 9 U.S. patents pending in addition to 34 PCTs internationally, with many more to be filed. Some of these PCT patents cover up to five products. All patents with Invisicare are owned by Skinvisible. Click here to learn more about our patents.

The Opportunity: New product formulations are expensive and time intensive. Pharmaceutical companies are pursuing new or improved revenue streams along with protecting their own IPs. Invisicare allows companies to sell a patent-protected product that has been revitalized with new benefits, providing a new story to help combat generic competitors. An Rx dermatology product can generate $100+ million per year; many even more - that's why a pharmaceutical company's investment into an Invisicare formulated product is a very viable option.
 
The Analyst Report
  February 2, 2009
  February 25, 2008
  July 21, 2008

Latest News:


July 31, 2009
Invisicare Approved For Additional US Patent - Further Intellectual Property Protection Enhances Skinvisible's Value

June 25, 2009
Skinvisible Receives Comprehensive Patent in China - Patent Protection For Invisicare Expands

May 4, 2009
Skinvisible in the News re H1N1



CLICK HERE TO READ ALL NEWS RELEASES



Signup for updates:
 
 
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.
 
 
 
 
 
 
 

 

 



 

 
 
 
 
 
 
 
Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.433.7192
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.
 
 
Skinvisible's value lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare®. Patent approvals are sought (initially in the U.S. and later internationally) for all products developed. There are 4 patents approved, 9 U.S. patents pending in addition to 34 PCTs internationally, with many more to be filed. Some of these PCT patents cover up to five products. All patents with Invisicare® are owned by Skinvisible.

Patent Components (Combined or Individually):



Granted Patents & Trademarks

United States Patents Granted

United States Patent No.:  6,756,059
Granted:  June 29, 2004
Topical composition, topical composition precursor, and methods for manufacturing and using.

Abstract
A topical composition is provided. The topical composition can be prepared by diluting a topical composition precursor with water and adding additional components, if desired. The topical composition precursor can be prepared by melt processing a hydrophobic polymer composition that includes repeating pyrrolidone/alkylene groups wherein the alkylene groups contain at least 10 carbon atoms, and a hydrophilic polymer composition including repeating carboxylic groups and/or repeating hydroxyl groups. A topical composition precursor and methods for manufacturing and using a topical composition are provided by the invention.

United States Patent No.:  6,582,683
Granted:  June 24, 2003
Dermal barrier composition.

Abstract
Disclosed is a dermal barrier composition which contains a hydrophilic polymer emulsion and a hydrophobic polymer emulsion. The dermal barrier composition is moisture activated, and remains inert until the hydrophobic and hydrophilic polymer emulsions contact a suitable substrate such as human skin. The dermal barrier composition is itself an emulsion, and can optionally contain a biocidal agent for antimicrobial and antiviral efficacy. The dermal barrier composition can also contain other active agents such as sunscreens, insect repellents and fungicides. The dermal barrier composition can be applied topically to skin, where it forms a protective or barrier layer against a number of pathogenic and chemical irritants.



International Patents Granted

India Patent No.:  2083999
Granted:  July 26, 2007
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Abstract
A topical composition is provided. The topical composition can be prepared by diluting a topical composition precursor with water and adding additional components, if desired. The topical composition precursor can be prepared by melt processing a hydrophobic polymer composition that includes repeating pyrrolidone/alkylene groups wherein the alkylene groups contain at least 10 carbon atoms, and a hydrophilic polymer composition including repeating carboxylic groups and/or repeating hydroxyl groups. A topical composition precursor and methods for manufacturing and using a topical composition are provided by the invention.


Australia Patent No.:  
Granted:  June 3, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Abstract
A topical composition is provided. The topical composition can be prepared by diluting a topical composition precursor with water and adding additional components, if desired. The topical composition precursor can be prepared by melt processing a hydrophobic polymer composition that includes repeating pyrrolidone/alkylene groups wherein the alkylene groups contain at least 10 carbon atoms, and a hydrophilic polymer composition including repeating carboxylic groups and/or repeating hydroxyl groups. A topical composition precursor and methods for manufacturing and using a topical composition are provided by the invention.




Pending Applications Globally

There are a number of patents ending in the United States and internationally. Skinvisible continues to file for patents with each new product formulation developed, and each new Invisicare polymer delivery system.

 
Latest Press Releases:


July 31, 2009
Invisicare Approved For Additional US Patent - Further Intellectual Property Protection Enhances Skinvisible's Value

June 25, 2009
Skinvisible Receives Comprehensive Patent in China - Patent Protection For Invisicare Expands

May 4, 2009
Skinvisible in the News re H1N1



CLICK HERE TO READ ALL NEWS RELEASES



  Research & Development
  Technology Overview
 
 
 
 
 
 
 
 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SKVI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
SKVI News: Quarterly Report (10-q) 11/17/2016 04:16:54 PM
SKVI News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/14/2016 01:59:06 PM
SKVI News: Current Report Filing (8-k) 11/08/2016 06:11:33 AM
SKVI News: Amended Statement of Beneficial Ownership (sc 13d/a) 11/03/2016 06:13:58 AM
SKVI News: Amended Statement of Beneficial Ownership (sc 13d/a) 11/02/2016 04:53:53 PM
PostSubject
#105   http://www.skinvisible.com/ OTCRIDER 11/03/16 06:34:54 PM
#104   Yikes mattypsays 08/15/16 10:38:17 AM
#103   $SKVI 3 months chart http://www.stockscores.co $Pistol Pete$ 04/03/16 03:31:13 PM
#102   "OMG!!!! SPAMMED BY THIS DUMP...!!!! Minuteman-MX 10/31/14 03:10:00 PM
#101   LOOKING TO OPEN AT .079 GO GO1 10/27/14 08:51:48 AM
#100   Where is Joe today. GO GO1 10/27/14 08:50:02 AM
#99   Hope I am right. GO GO1 10/27/14 08:49:20 AM
#98   It's the 4th Quarter, GO GO1 10/27/14 08:45:02 AM
#97   Good news is coming. GO GO1 10/27/14 08:43:30 AM
#96   Anybody else on the board? GO GO1 10/27/14 08:41:59 AM
#95   Looking for .105 today. GO GO1 10/27/14 08:37:45 AM
#94   Looking for .105 today. GO GO1 10/27/14 08:36:26 AM
#93   Launch in the 4th quarter of this year GO GO1 10/26/14 05:07:08 PM
#92   Anybody out there.THE STOCK IS AT .08 CENTS GO GO1 10/24/14 07:29:35 PM
#91   $SKVI DD Notes ~ http://www.ddnotesmaker.com/SKVI stocktrademan 10/22/14 10:55:02 AM
#90   $skvi might boom of the roof $$$$ Goodtrader1 04/28/14 08:01:25 AM
#89   What's going on here? This just popped up Chrion Capital 04/25/14 01:42:04 PM
#88   NIce bounce cofca 04/25/14 10:40:03 AM
#87   It's dated 2011. Old news Gixxer 04/25/14 10:14:01 AM
#86   Looks like there was no one to see cofca 04/25/14 10:07:42 AM
#85   wow huge news [SMART MONEY] 03/25/14 11:12:40 AM
#84   http://www.pumpsanddumps.com/ mkinhaw 02/10/13 07:15:09 PM
#83   NEWS - Skinvisible's DermSafe Hand Sanitizer Recommended by m0j0s 12/16/11 07:13:57 AM
#82   Skinvisible Licensee Launches First Prescription Product in the ragmuff 07/18/11 09:13:31 AM
#81   Anyone know why this has stopped trading? TriPpPn 03/21/11 12:44:47 AM
#80   NEW-Skinvisible Awarded Comprehensive Invisicare Patent m0j0s 03/03/11 11:34:00 AM
#79   /Users/hansverbeek/Desktop/SKVI.OB_ Summary for SKINVISIBLE INC- Yahoo! Finance. hansjusdorange 02/23/11 06:37:53 PM
#78   Why do we have trades @ ,10 on hansjusdorange 02/23/11 06:34:32 PM
#77   This news looks great. I hope this Snakecharmer 02/01/11 09:46:58 AM
#76   Skinvisible Pharmaceuticals Enters Into Feasibility Study With Major gst 02/01/11 09:44:22 AM
#75   THE REAL DEALLLLLLLLL gst 02/01/11 09:38:29 AM
#74   SKVI MAJOR NEWSSSSSSSSSSSSSSSSS gst 02/01/11 09:36:54 AM
#73   SKVI MAJOR NEWSSSSSSSSSSSSSSSSS gst 02/01/11 09:36:51 AM
#72   SKVI MAJOR NEWSSSSSSSSSSSSSSSSS gst 02/01/11 09:36:45 AM
#71   Looks like this company has morphed into another gary_17368 11/24/10 12:53:46 PM
#70   yeah, like zero volume, literally :) schlitz 04/14/10 11:47:56 AM
#69   yes this is great news....to bad no one bondoman 04/14/10 09:56:33 AM
#68   This is very good news going forward into schlitz 04/13/10 10:52:08 AM
#67   Skinvisible Signs Development Agreement for Prescription Product for schlitz 04/13/10 10:51:01 AM
#66   Great finish today!!! TriPpPn 03/25/10 01:39:56 AM
#65   Skinvisible Granted Patent for South Korea! TriPpPn 03/24/10 02:47:50 AM
#64   Still this company is not on anybodys radar bondoman 02/12/10 09:47:27 AM
#63   Skinvisible's Safe4Hours Promotion in Walgreens Expands!!! TriPpPn 02/11/10 06:09:05 PM
#62   Anyone know of any news? TriPpPn 02/10/10 02:13:10 PM
#61   Does anyone even follow this board??? TriPpPn 01/28/10 08:34:08 PM
#60   This is great news!!! TO THE MOON!!! TriPpPn 01/28/10 08:25:49 PM
#59   Reorder 2 weeks after Walgreens deal! 73m float zeno7 01/28/10 11:01:02 AM
#58   Skinvisible Licensee Receives Reorder from Walgreens zeno7 01/28/10 10:58:40 AM
#57   Why the low volume today? Is something TriPpPn 01/15/10 03:32:20 PM
#56   Technically, SKVI is upgraded to buy with the alhigou 01/13/10 12:08:55 PM
PostSubject